Viking Therapeutics, Inc. · Brief

Next report

102 days

Feb 10 · after closeest.Q4 FY26

Expected move

±23.3%implied · straddle

20.9333.63

spot 27.28exp Feb 19ATM strike 27.5ATM straddle 7.47IV 62%

Oct 30 closeprovisional

Expected move

2 reportsHistory

—≥ implied

Q2 FY26—▼−0.96%—

Q3 FY26±6.5%▲+5.91%×0.91

quarterimplied−10%0+10%realized×

Q3 FY26±6.5%▲+5.91%×0.91

Q2 FY26—▼−0.96%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Feb 10 report · est.

—

VKTX report session

No linked exposure.

Oct 21report dateEarnings date confirmed: Oct 28, after close.Source

Oct 21impliedImplied move: ±7.4% into Oct 28 earnings (Oct 21 close).Source

Oct 7impliedImplied move: ±9.8% into Oct 21 earnings (Oct 7 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.